January 27, 2026January 27, 2026 Shares of Wockhardt Ltd are trading flat after touching a day’s high of Rs 1,411.90 on 27th January. This comes despite the firm announcing that its antibiotic Foviscu successfully met the primary endpoint in a phase 3 clinical trial involving patients with complicated urinary…
July 28, 2025July 28, 2025 Shares of Wockhardt Ltd surged 5% to touch a day’s high of Rs 1,775 on 28th July, after the company stated a medical case where its novel antibiotic Zaynich was used to treat a critically ill US liver transplant patient…
January 3, 2025January 3, 2025 Shares of Wockhardt Ltd skyrocketed 9% on 3 January after the Indian pharma authority approved an oral antibiotic for the treatment of pneumonia. The Central Drugs Standard Control Organization (CDSCO) has authorized the antibiotic Nafithromycin, which is sold under the brand name Miqnaf, as…